Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 10

1.

Insulin degludec: Lower day-to-day and within-day variability in pharmacodynamic response compared with insulin glargine 300 U/mL in type 1 diabetes.

Heise T, Nørskov M, Nosek L, Kaplan K, Famulla S, Haahr HL.

Diabetes Obes Metab. 2017 Jul;19(7):1032-1039. doi: 10.1111/dom.12938. Epub 2017 Apr 23.

2.

Glucose Exposure and Variability with Empagliflozin as Adjunct to Insulin in Patients with Type 1 Diabetes: Continuous Glucose Monitoring Data from a 4-Week, Randomized, Placebo-Controlled Trial (EASE-1).

Famulla S, Pieber TR, Eilbracht J, Neubacher D, Soleymanlou N, Woerle HJ, Broedl UC, Kaspers S.

Diabetes Technol Ther. 2017 Jan;19(1):49-60. doi: 10.1089/dia.2016.0261. Epub 2016 Dec 8.

PMID:
27929674
3.

Insulin Injection Into Lipohypertrophic Tissue: Blunted and More Variable Insulin Absorption and Action and Impaired Postprandial Glucose Control.

Famulla S, Hövelmann U, Fischer A, Coester HV, Hermanski L, Kaltheuner M, Kaltheuner L, Heinemann L, Heise T, Hirsch L.

Diabetes Care. 2016 Sep;39(9):1486-92. doi: 10.2337/dc16-0610. Epub 2016 Jul 13.

PMID:
27411698
4.

Empagliflozin as adjunct to insulin in patients with type 1 diabetes: a 4-week, randomized, placebo-controlled trial (EASE-1).

Pieber TR, Famulla S, Eilbracht J, Cescutti J, Soleymanlou N, Johansen OE, Woerle HJ, Broedl UC, Kaspers S.

Diabetes Obes Metab. 2015 Oct;17(10):928-35. doi: 10.1111/dom.12494. Epub 2015 Jun 24.

6.

Heat shock protein 60 as a mediator of adipose tissue inflammation and insulin resistance.

Märker T, Sell H, Zillessen P, Glöde A, Kriebel J, Ouwens DM, Pattyn P, Ruige J, Famulla S, Roden M, Eckel J, Habich C.

Diabetes. 2012 Mar;61(3):615-25. doi: 10.2337/db10-1574. Epub 2012 Feb 7.

7.

Hypoxia reduces the response of human adipocytes towards TNFα resulting in reduced NF-κB signaling and MCP-1 secretion.

Famulla S, Horrighs A, Cramer A, Sell H, Eckel J.

Int J Obes (Lond). 2012 Jul;36(7):986-92. doi: 10.1038/ijo.2011.200. Epub 2011 Oct 18.

PMID:
22005720
8.

Identification and validation of novel adipokines released from primary human adipocytes.

Lehr S, Hartwig S, Lamers D, Famulla S, Müller S, Hanisch FG, Cuvelier C, Ruige J, Eckardt K, Ouwens DM, Sell H, Eckel J.

Mol Cell Proteomics. 2012 Jan;11(1):M111.010504. doi: 10.1074/mcp.M111.010504. Epub 2011 Sep 26.

9.

Dipeptidyl peptidase 4 is a novel adipokine potentially linking obesity to the metabolic syndrome.

Lamers D, Famulla S, Wronkowitz N, Hartwig S, Lehr S, Ouwens DM, Eckardt K, Kaufman JM, Ryden M, Müller S, Hanisch FG, Ruige J, Arner P, Sell H, Eckel J.

Diabetes. 2011 Jul;60(7):1917-25. doi: 10.2337/db10-1707. Epub 2011 May 18.

10.

Pigment epithelium-derived factor (PEDF) is one of the most abundant proteins secreted by human adipocytes and induces insulin resistance and inflammatory signaling in muscle and fat cells.

Famulla S, Lamers D, Hartwig S, Passlack W, Horrighs A, Cramer A, Lehr S, Sell H, Eckel J.

Int J Obes (Lond). 2011 Jun;35(6):762-72. doi: 10.1038/ijo.2010.212. Epub 2010 Oct 12.

PMID:
20938440

Supplemental Content

Loading ...
Support Center